Policies and Position Statements

Policies

High Cost Drugs routinely commissioned in North West London 2025 / 2026

Medicines not reimbursed through national prices funded by NHS North West London ICB

North West London Interface Prescribing Policy 2025 / 2026

This policy, developed in collaboration with system partners involved in NHS prescribing and drug services, outlines best practice recommendations for medicines prescribed in North West London.

Position Statements 

North West London Position statement on prescribing of shower protection pouches for dialysis patients 

North West London ICB, in collaboration with the Renal and Transplant Centre team at Imperial College NHS Healthcare Trust, does not support the prescribing of shower protection pouches or related products.

Interim position statement: Prescribing semaglutide (Wegovy®) and tirzepatide (Mounjaro®) for weight management on the NHS in North West London

This interim statement sets out NW London’s criteria for NHS access to NICE-approved weight management medications, Wegovy® (semaglutide) and Mounjaro® (tirzepatide), in line with NHSE guidance and local clinical input.

NHS North West London position statement on prescribing branded generic medicines

Outlines NHS North West London’s position against routine prescribing of branded generics in primary care, highlighting cost implications and benefits of using standard generics for patient access and pharmacy sustainability.

Primary Care Rebate Scheme

NHS North West London Primary Care Rebate Schemes

This document lists the primary care rebate schemes NHS North West London is currently signed up to.